Next Article in Journal
Ornidazole Transfer into Colostrum and Assessment of Exposure Risk for Breastfeeding Infant: A Population Pharmacokinetic Analysis
Next Article in Special Issue
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
Previous Article in Journal
Gene and Cellular Therapies for Leukodystrophies
Previous Article in Special Issue
Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(11), 2523; https://doi.org/10.3390/pharmaceutics15112523
Action Date Notes Link
article xml file uploaded 24 October 2023 11:43 CEST Original file -
article xml uploaded. 24 October 2023 11:43 CEST Update https://www.mdpi.com/1999-4923/15/11/2523/xml
article pdf uploaded. 24 October 2023 11:43 CEST Version of Record https://www.mdpi.com/1999-4923/15/11/2523/pdf
article html file updated 24 October 2023 11:44 CEST Original file https://www.mdpi.com/1999-4923/15/11/2523/html
Back to TopTop